WO2023017383 - A HEMATOLOGY ANALYZER COMPRISING A SINGLE HARDWARE MODULE AND INTEGRATED WORKFLOW
National phase entry:
Publication Number
WO/2023/017383
Publication Date
16.02.2023
International Application No.
PCT/IB2022/057301
International Filing Date
05.08.2022
Title **
[English]
A HEMATOLOGY ANALYZER COMPRISING A SINGLE HARDWARE MODULE AND INTEGRATED WORKFLOW
[French]
ANALYSEUR D'HÉMATOLOGIE COMPRENANT UN MODULE MATÉRIEL UNIQUE ET UN FLUX DE TRAVAIL INTÉGRÉ
Applicants **
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Inventors
MACH, Tivadar
PAULICKA, Peter
SELIGER, Ramona
STELLING, Frederick
Priority Data
21190254.9
09.08.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2322 | |
| EPO | Filing, Examination, Granting | 9326 | |
| Japan | Filing, Examination, Granting | 2172 | |
| South Korea | Filing, Examination, Granting | 2039 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,599
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The disclosure relates to a device and method for analyzing a blood sample, particularly including pre-analytical (qualification), analytical and post-analytical (verification) testing. More particularly the disclosure relates in certain embodiments to a device configured for collecting, imaging and lysing blood cells in a sample vessel by means of ultrasonic acoustic waves, generated in the vessel by an acoustic transducer driven at one particular excitation frequency or more particular excitation frequencies, or one range of frequency or ranges of frequencies. In some non-limiting embodiments, the ultrasonic acoustic waves are generated by a single acoustic transducer. Further on, according to certain embodiments, the device and workflow are configured for three analytical steps in single device, comprising pre-analytical (qualification), analytical and post-analytical (verification) testing.[French]
La divulgation concerne un dispositif et un procédé d'analyse d'un échantillon de sang, comprenant notamment des tests préanalytiques (qualification), analytiques et post-analytiques (vérification). Plus particulièrement, la divulgation concerne dans certains modes de réalisation un dispositif configuré pour collecter, imager et lyser des cellules sanguines dans un récipient d'échantillon au moyen d'ondes acoustiques ultrasonores, générées dans le récipient par un transducteur acoustique piloté à une ou plusieurs fréquences d'excitation particulières, ou une ou plusieurs plages de fréquences. Dans certains modes de réalisation non limitatifs, les ondes acoustiques ultrasoniques sont générées par un seul transducteur acoustique. En outre, selon certains modes de réalisation, le dispositif et le flux de travail sont configurés pour trois étapes analytiques dans un seul dispositif, comprenant des tests préanalytiques (qualification), analytiques et post-analytiques (vérification).